FOR IMMEDIATE RELEASE
December 15, 2016
Partnership for Clean Competition
COLORADO SPRINGS, Colo. The PGA TOUR, a Contributor to the Partnership for Clean Competition since 2008, has renewed its commitment to protecting clean athletes through a four-year investment in the science that fuels innovation in anti-doping knowledge and technology.
As a PCC Contributor, the PGA TOUR directly supports the scientific discovery of less invasive and expensive methods for acquiring athlete samples, enhanced testing and analysis methodologies, and reliable detection of novel and designer drugs.
The PGA TOUR has long recognized the important role of scientific research in the effective deterrence of doping in sport. Dr. Tom Hospel, The PGA TOUR’s Anti-Doping Medical Adviser, recently affirmed this sentiment, stating “anti-doping research is critical to the